Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
35
-
Total shares
-
9.85M
-
Shares change
-
-2.46M
-
Total reported value, excl. options
-
$16.8M
-
Value change
-
-$4.96M
-
Put/Call ratio
-
0.67
-
Number of buys
-
14
-
Number of sells
-
-26
-
Price
-
$1.70
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q3 2017
37 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q3 2017.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.85M shares
.
Largest 10 shareholders include Wildcat Capital Management, LLC (2.8M shares), VANGUARD GROUP INC (2.18M shares), Intellectus Partners, LLC (1.54M shares), BlackRock Inc. (668K shares), MILLENNIUM MANAGEMENT LLC (553K shares), GEODE CAPITAL MANAGEMENT, LLC (461K shares), DEUTSCHE BANK AG\ (357K shares), RENAISSANCE TECHNOLOGIES LLC (234K shares), NORTHERN TRUST CORP (174K shares), and BANK OF AMERICA CORP /DE/ (144K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.